Hunter C Smith Insider Trading Activity
Hunter C Smith has been net-selling over the last 12 months with 0 purchases and 24 sales across 1 company.
RYTM is the most-traded position with 24 trades. The largest single transaction was a sale of RYTM for $2.4M on Aug 12, 2025.
Performance Scorecard
Forward stock performance after each transaction by Hunter C Smith. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +7.0% | 76% | 29 |
| 90 days | — | +0.4% | 76% | 29 |
| 120 days | — | -0.5% | 69% | 29 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRYTM · RHYTHM PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Hunter C Smith bought and sold RYTM.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Feb 19, 2026 | RYTM | Sell | 585 | $103.28 | $60K | −0.5% | CFO | |
Feb 19, 2026 | RYTM | Sell | 1,308 | $100.27 | $131K | −1.1% | CFO | |
Feb 19, 2026 | RYTM | Sell | 1,692 | $100.92 | $171K | −1.5% | CFO | |
Feb 19, 2026 | RYTM | Sell | 800 | $102.10 | $82K | −0.7% | CFO | |
Feb 17, 2026 | RYTM | Sell | 1,200 | $99.42 | $119K | −1.0% | CFO | |
Feb 17, 2026 | RYTM | Sell | 200 | $100.52 | $20K | −0.2% | CFO | |
Feb 17, 2026 | RYTM | Sell | 900 | $101.70 | $92K | −0.8% | CFO | |
Feb 17, 2026 | RYTM | Sell | 1,069 | $103.00 | $110K | −0.9% | CFO | |
Feb 12, 2026 | RYTM | Sell | 292 | $96.26 | $28K | −0.2% | CFO | |
Feb 12, 2026 | RYTM | Sell | 400 | $97.67 | $39K | −0.3% | CFO | |
Feb 12, 2026 | RYTM | Sell | 800 | $98.99 | $79K | −0.7% | CFO | |
Feb 12, 2026 | RYTM | Sell | 100 | $100.10 | $10K | −0.1% | CFO | |
Feb 11, 2026 | RYTM | Sell | 400 | $99.44 | $40K | −0.3% | CFO | |
Feb 11, 2026 | RYTM | Sell | 100 | $100.85 | $10K | −0.1% | CFO | |
Feb 11, 2026 | RYTM | Sell | 2,266 | $98.37 | $223K | −1.8% | CFO | |
Feb 10, 2026 | RYTM | Sell | 700 | $103.68 | $73K | −0.6% | CFO | |
Feb 10, 2026 | RYTM | Sell | 100 | $104.76 | $10K | −0.1% | CFO | |
Feb 10, 2026 | RYTM | Sell | 1,913 | $102.66 | $196K | −1.5% | CFO | |
Feb 5, 2026 | RYTM | Sell | 3,381 | $106.06 | $359K | −2.6% | CFO | |
Feb 4, 2026 | RYTM | Sell | 1,000 | $106.60 | $107K | −0.8% | CFO | |
Feb 4, 2026 | RYTM | Sell | 1,500 | $104.74 | $157K | −1.1% | CFO | |
Feb 4, 2026 | RYTM | Sell | 747 | $107.67 | $80K | −0.6% | CFO | |
Aug 13, 2025 | RYTM | Sell | 3,477 | $96.00 | $334K | −2.9% | CFO | |
Aug 12, 2025 | RYTM | Sell | 24,611 | $96.33 | $2.4M | −17.4% | CFO | |
Jul 9, 2025 | RYTM | Sell | 17,113 | $75.38 | $1.3M | −10.8% | CFO | |
Jul 9, 2025 | RYTM | Sell | 1,607 | $76.17 | $122K | −1.1% | CFO | |
Jul 9, 2025 | RYTM | Sell | 23,400 | $84.50 | $2.0M | −16.7% | CFO | |
May 30, 2025 | RYTM | Sell | 18,993 | $61.52 | $1.2M | −14.7% | CFO | |
May 30, 2025 | RYTM | Sell | 4,407 | $60.93 | $269K | −3.3% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 29 | $9.7M |
Other insiders at RHYTHM PHARMACEUTICALS, INC.
3 other tracked filers at RYTM.